Firm News: Drugs & Devices: Page 9

Ellen Relkin to Speak at ABA Event in October

W&L Of Counsel attorney Ellen Relkin will be a featured speaker at an October seminar sponsored by the American Bar Association on pharmaceutical, medical device and biotech litigation. The seminar will address a number of topics of importance to attorneys who focus on cases involving defective drugs and medical devices. Ms. Relkin is a nationally…

W&L Investigating Injuries Caused by Recalled Beacon Tip Angiographic Catheters from Cook Medical

Weitz & Luxenberg, P.C., today launched an investigation into injuries sustained by patients when catheters used during cardiac angiogram procedures to inject contrast dye into blood vessels malfunctioned by either splitting or separating.   The probe centers around one particular brand of angiographic catheters made by Cook Medical of Bloomington, Indiana. The recall, classified as…

W&L Investigating EMPERION Modular Hip System Cases

W&L is investigating cases of fracture associated with the EMPERION Modular Hip System manufactured by Smith & Nephew Inc. of Memphis, Tennessee. The investigation was prompted by recent medical literature, fracture and revision reports discovered in the U.S. Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database, and an analysis by…

HarrisMartin’s MDL Conference Features W&L Attorney As Invited Faculty

W&L attorney David L. Rosenband has been invited as a faculty member for the upcoming HarrisMartin MDL Conference: Zofran, Bard IVC and Zimmer Persona Knee Litigation. Rosenband serves as an associate attorney on our Defective Drugs and Devices team. An experienced litigator, he has been involved in a number of significant medical device and pharmaceutical…

Taking SGLT2 Inhibitors May Result in Diabetic Ketoacidosis

W&L is now accepting cases of diabetic ketoacidosis that resulted in the hospitalization or death of people who ingested any of the sodium glucose cotransporter-2 (SGLT2) inhibitors. SGLT2 inhibitors are a class of medications indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This drug…

Get the Help You Need Today

Free Case Review